{"id":2659,"date":"2024-06-05T04:56:43","date_gmt":"2024-06-04T21:56:43","guid":{"rendered":"https:\/\/hataphar.com.vn\/?page_id=2659"},"modified":"2025-07-23T16:09:23","modified_gmt":"2025-07-23T09:09:23","slug":"shareholder-information","status":"publish","type":"page","link":"https:\/\/hataphar.com.vn\/en\/shareholder-information\/","title":{"rendered":"Shareholder information"},"content":{"rendered":"
\n \n
\n Business news<\/a>\n Storage<\/a>\n File<\/a>\n Business<\/a>\n<\/div>\n \n\n\n
\n
\n

Business news published<\/p>\n <\/span>\n <\/div>\n\n

\n \n
\n
\n Notice of change of Information Disclosure Officer<\/a>\n
01\/04\/2026<\/div>\n <\/div>\n\n \n \n \n
\n Minutes 2026 Annual Genneral meeting of shareholders Ha Tay Pharmaceutical Joint Stock Company<\/a>\n
31\/03\/2026<\/div>\n <\/div>\n\n \n \n \n
\n Change in personnel<\/a>\n
31\/03\/2026<\/div>\n <\/div>\n\n \n \n \n
\n Resolution of the Board of Directors regarding the organnizational an personnel consolidation of the Board of Directors and the Executive Board<\/a>\n
30\/03\/2026<\/div>\n <\/div>\n\n \n \n \n
\n Resolution of the Board of Directors regarding the corporate governance and the operational apparatus<\/a>\n
30\/03\/2026<\/div>\n <\/div>\n\n \n \n \n
\n Resolution of the Board of Directors regarding financial borrowing, investment, and corporate transactions<\/a>\n
30\/03\/2026<\/div>\n <\/div>\n\n \n \n \n
\n Annual Report 2025<\/a>\n
24\/03\/2026<\/div>\n <\/div>\n\n \n \n \n
\n Separate Financial Statements FY2025<\/a>\n
16\/03\/2026<\/div>\n <\/div>\n\n \n \n \n
\n Consolidated Financial Statements FY2025<\/a>\n
16\/03\/2026<\/div>\n <\/div>\n\n \n \n \n
\n Notice of the 2026 annual general meeting of shareholders<\/a>\n
06\/03\/2026<\/div>\n <\/div>\n\n <\/div>\n \n
\n
\n Financial Statement Quarter 4 \u2013 2025<\/a>\n
28\/01\/2026<\/div>\n <\/div>\n\n \n \n \n
\n Consolidated Financial Statement Quarter 4 \u2013 2025<\/a>\n
28\/01\/2026<\/div>\n <\/div>\n\n \n \n \n
\n Financial Statement Quarter 3 \u2013 2025<\/a>\n
28\/10\/2025<\/div>\n <\/div>\n\n \n \n \n
\n Consolidated Financial Statement Quarter 3 \u2013 2025<\/a>\n
28\/10\/2025<\/div>\n <\/div>\n\n \n \n \n
\n Reviewed Interim Separate Financial Statements 2025<\/a>\n
26\/08\/2025<\/div>\n <\/div>\n\n \n \n \n
\n Reviewed Interim Consolidated Financial Statements 2025<\/a>\n
26\/08\/2025<\/div>\n <\/div>\n\n \n \n \n
\n Financial Statement Quarter 2 \u2013 2025<\/a>\n
23\/07\/2025<\/div>\n <\/div>\n\n \n \n \n
\n Consolidated Financial Statement Quarter 2 \u2013 2025<\/a>\n
23\/07\/2025<\/div>\n <\/div>\n\n \n \n \n
\n Consolidated Financial Statement Quarter 1 \u2013 2025<\/a>\n
24\/04\/2025<\/div>\n <\/div>\n\n \n \n \n
\n Financial Statement Quarter 1 \u2013 2025<\/a>\n
24\/04\/2025<\/div>\n <\/div>\n\n <\/div>\n <\/div>\n\n <\/div>\n\n
\n 1<\/span>\n2<\/a>\nNext \u00bb<\/a> <\/div>\n<\/div>\n\n\t
\n\t\t
\n\n\t\t\t\n\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t
\n\t\t\t\n
\n
\n
\n
\n\n\n\n
BASIC FINANCIAL INDICATORS<\/strong><\/td>\nUpdated as of Q2 2025 <\/em><\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Revenue Growth<\/td>\n16.32<\/td>\n<\/tr>\n
Net Profit Growth<\/td>\n-37.45<\/td>\n<\/tr>\n
Total Asset Growth<\/td>\n4.01<\/td>\n<\/tr>\n
\u00a0<\/td>\n<\/tr>\n
ROA<\/td>\n1.09<\/td>\n<\/tr>\n
ROE<\/td>\n3.22<\/td>\n<\/tr>\n
ROA for the last 4 quarters<\/td>\n4.09<\/td>\n<\/tr>\n
ROE for the last 4 quarters<\/td>\n7.24<\/td>\n<\/tr>\n
\u00a0<\/td>\n<\/tr>\n
Current Ratio<\/td>\n1.21<\/td>\n<\/tr>\n
Quick Ratio<\/td>\n0.53<\/td>\n<\/tr>\n
\u00a0<\/td>\n<\/tr>\n
Debt-to-Equity Ratio<\/td>\n0.83<\/td>\n<\/tr>\n
Leverage Ratio (Total Assets\/Shareholders’ Equity)<\/td>\n1.83<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<\/div><\/div>\n
\n
\n
\n
\n\n\n\n
REPORTING INDICATORS<\/strong><\/td>\nUpdated as of Q2 2025<\/em><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Revenue from sales of goods and services<\/td>\n1,070,570<\/td>\n<\/tr>\n
Gross profit from sales of goods and services<\/td>\n107,326<\/td>\n<\/tr>\n
Net profit\/loss from operating activities<\/td>\n38,850<\/td>\n<\/tr>\n
Net profit\/loss before tax<\/td>\n45,673<\/td>\n<\/tr>\n
Net profit\/loss after income tax<\/td>\n37,320<\/td>\n<\/tr>\n
\u00a0<\/td>\n<\/tr>\n
Current assets<\/td>\n983,001<\/td>\n<\/tr>\n
Total assets<\/td>\n2,003,483<\/td>\n<\/tr>\n
Current liabilities<\/td>\n809,195<\/td>\n<\/tr>\n
Non-current liabilities<\/td>\n101,756<\/td>\n<\/tr>\n
Shareholders’ equity<\/td>\n1,092,531<\/td>\n<\/tr>\n
Owners’ equity<\/td>\n823,418<\/td>\n<\/tr>\n
VND million<\/em>
<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<\/div>\n<\/div><\/div>\n\n